Literature DB >> 12732206

ULBP4 is a novel ligand for human NKG2D.

N Jan Chalupny1, Claire L Sutherland, William A Lawrence, Annie Rein-Weston, David Cosman.   

Abstract

The ULBPs are a family of MHC class I-related molecules. We have previously shown that ULBPs 1, 2, and 3 are functional ligands of the NKG2D/DAP10 receptor complex on human natural killer (NK) cells. Here, we describe a new member of the ULBP family, ULBP4, which contains predicted transmembrane and cytoplasmic domains, unlike the other ULBPs, which are GPI-linked proteins. Transduction of ULBP4 into EL4 cells confers the ability to bind recombinant NKG2D and mediates increased cytotoxic activity by human NK cells, consistent with the role of ULBPs as ligands for the NKG2D/DAP10 activating receptors. Tissue expression of ULBP4 differs from other members of the family, in that it is expressed predominantly in the skin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732206     DOI: 10.1016/s0006-291x(03)00714-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  65 in total

Review 1.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

Review 2.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Immunol Cell Biol       Date:  2016-01-06       Impact factor: 5.126

Review 4.  NKG2D in NK and T cell-mediated immunity.

Authors:  Kouetsu Ogasawara; Lewis L Lanier
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

5.  The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa.

Authors:  Michael T Borchers; Nathaniel L Harris; Scott C Wesselkamper; Shiping Zhang; Yi Chen; Lisa Young; Gee W Lau
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.

Authors:  Changlin Li; Baoxue Ge; Matthew Nicotra; Joel N H Stern; Hernan D Kopcow; Xi Chen; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

7.  NKG2D Ligands in Cancer Immunotherapy: Target or Not?

Authors:  Jennifer Wu
Journal:  Austin J Clin Immunol       Date:  2014-01-06

Review 8.  Immunogenetics of the NKG2D ligand gene family.

Authors:  Masanori Kasahara; Shigeru Yoshida
Journal:  Immunogenetics       Date:  2012-07-29       Impact factor: 2.846

9.  Divergence and diversity of ULBP2 genes in rhesus and cynomolgus macaques.

Authors:  Taeko K Naruse; Hirofumi Akari; Tetsuro Matano; Akinori Kimura
Journal:  Immunogenetics       Date:  2014-01-28       Impact factor: 2.846

10.  Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands.

Authors:  Steffen Müller; Georg Zocher; Alexander Steinle; Thilo Stehle
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.